Truist reduced its price target on DaVita, which is in Warren Buffett's investment portfolio, citing mixed short-term outlook.
1 report, 1 independent
Updated Aug 1
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Truist reduced its price target on DaVita, which is in Warren Buffett's investment portfolio, citing mixed short-term outlook.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
DaVita
renal dialysis center chain based in the United States
Nothing else this week.
-
Warren Buffett
American investor, entrepreneur and businessman
Coverage
Newest first; wire copies grouped- Insider MonkeyTruist Reduces PT on DaVita Inc. (DVA) from $170 to $164; Zacks Keeps ‘Hold’ Rating With a low price-to-earnings multiple and a significant presence in Warren Buffett’s investment portfolio, DaVita I